✦ LIBER ✦

In vitro and In vivo radiation sensitivity of glioblastoma multiforme: Correction

✍ Scribed by A. Taghian; H. Suit; M. Baumann

Publisher: Elsevier Science
Year: 1996
Tongue: English
Weight: 301 KB
Volume: 35
Category: Article
ISSN: 0360-3016
DOI: 10.1016/0360-3016(96)85888-3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

In vivo radiation sensitivity of gliobla

In vivo radiation sensitivity of glioblastoma multiforme

✍ Alphonse Taghian; Willem duBois; Wilfried Budach; Michael Baumann; Jill Freeman; 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 679 KB

Evaluation of novel radiation sensitizer

Evaluation of novel radiation sensitizers in vitro and in vivo

✍ G.E. Adams; P.W. Sheldon; I.J. Stratford 📂 Article 📅 1982 🏛 Elsevier Science 🌐 English ⚖ 374 KB

Levamisole in the treatment of glioblast

Levamisole in the treatment of glioblastoma multiforme

✍ Sharon P. Fischer; John Lindermuth; Cecil Hash; Henry A. Shenkin 📂 Article 📅 1985 🏛 John Wiley and Sons 🌐 English ⚖ 183 KB

Bromodeoxyuridine labeling index in glio

Bromodeoxyuridine labeling index in glioblastoma multiforme: Relation to radiation response, age, and survival

✍ Fred G. Barker II; Michael D. Prados; Susan M. Chang; Richard L. Davis; Philip H 📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 957 KB

In vivo and in vitro radiation responses

In vivo and in vitro radiation responses of a sensitive spontaneous mouse mammary adenocarcinoma

✍ James Shaeffer; Anas M. El-Mahdi; Timothy Merz 📂 Article 📅 1972 🏛 John Wiley and Sons 🌐 English ⚖ 333 KB 👁 2 views

Contrasting in vivo and in vitro fates o

Contrasting in vivo and in vitro fates of glioblastoma cell subpopulations with amplified EGFR

✍ Ajay Pandita; Kenneth D. Aldape; Gelareh Zadeh; Abhijit Guha; C. David James 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 466 KB

Despite the high incidence of EGFR amplification in patient glioblastoma multiforme (GBM) tissues, only a single GBM cell line, of the many described in the literature, is known to contain and maintain amplified EGFR. Because EGFR mutations in GBM manifest primarily, if not exclusively, in amplified